Links

Information and resources regarding cancer, cancer treatments, and local support.

Information on Arimidex, an aromatase inhibitor that is often prescribed to ESS survivors.

AROMASIN® (exemestane tablets) is a prescription medicine for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer (or ESS in our case). It is an irreversible steroidal aromatase inhibitor.

Connecting patients with services and support.

The multidisciplinary expert team at Cedars-Sinai's Sarcoma Center at the Samuel Oschin Comprehensive Cancer Institute in Los Angeles, California have extensive experience treating patients with sarcoma.

Dr. Forscher is a sarcoma specialist with Cedars-Sinai (Los Angeles, California) and is seeing at least two ESS patients at this time.

Located in Boston, Massachusetts. The Center for Sarcoma and Bone Oncology has dedicated specialty expertise in the pathologic and radiologic assessment of sarcoma.

Wikipedia article on uterine sarcomas.

Femara® (letrozole tablets) is approved for the adjuvant (following surgery) treatment of postmenopausal women with hormone receptorñpositive early stage breast cancer (or ESS). It is a reversible aromatase inhibitor.

Supporting you before, during and after your hysterectomy and other pelvic surgeries.

The University of Texas' MD Anderson Cancer Center, located in Houston, Texas.

Megestrol acetate, commonly known as Megace®, is a man-made substance called a progestogen which is similar to the female hormone progesterone. It is a type of drug known as hormonal therapy.

Located in New York, NY. The world's oldest and largest private cancer center, Memorial Sloan-Kettering Cancer Center (MSKCC) has devoted more than a century to patient care as well as to innovative research.

Medical term dictionary with pronunciations.

MyLifeLine exists to easily connect cancer patients and caregivers with friends and family in order to reduce stress, anxiety and isolation.

For the general public, patients, and health professionals, we offer consumer-oriented information on a wide range of topics as well as comprehensive descriptions of our research programs and clinical trials.

NORD, a 501(c)(3) organization, is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them.  NORD, along with its more than 300 patient organization members,  is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.

Dr. Sabbatini is on staff at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, New York.

The goal of the R.A. Bloch Cancer Foundation is to support cancer patients with information, moral support, and treatment assistance.

Dr. Penson is the Clinical Director of the Gillette Center for Gynecologic Oncology at Massachusetts General Hospital.

Suzanne Leider founded the Sarcoma Alliance in 1999 in the living room of her home with the mantra ìguidance, education, and supportî in her head.

The mission of the Sarcoma Foundation of America is to act as an advocate for increased research to find new and better therapies with which to treat patients with sarcoma.

How to read your pathology report from Cancer.net.